Mr. Sztybel was on the founding team of Imagine Bio. In his previous work, he led Life Sciences Advisory at EY Israel and served as a member of EY’s Global “Pharma 3.0″ team, in which capacity he recognized the potential of Israel as an innovation center for Digital Health already in 2011. His current advisory work is focused on working with MNCs to develop their global digital health strategy, including scouting, business model definition, and setting up collaborations with startup companies. Recent projects include strategic advisory for multinational pharma and healthcare companies, startups, as well as venture investors. He is also the cofounder of the DigitalHealth.il Conference – Israel’s oldest digital health focused conference and a cofounder of MyndYou, a digital health startup in the field of cognitive impairment.

Dan has a strong background in molecular biology and was part of a PhD program in molecular genetics at the Weizmann Institute in Israel. Early in his career, Dan worked as a research scientist at EvoGene and Compugen, and as an IP Patent assistant at Ehrlich & Fenster. He is fluent in English, Hebrew, French, and Flemish.